Exploring short-term responses to changes in the control strategy for chlamydia trachomatis (Q428305): Difference between revisions

From MaRDI portal
Added link to MaRDI item.
ReferenceBot (talk | contribs)
Changed an Item
 
(2 intermediate revisions by 2 users not shown)
Property / MaRDI profile type
 
Property / MaRDI profile type: MaRDI publication profile / rank
 
Normal rank
Property / full work available at URL
 
Property / full work available at URL: https://doi.org/10.1155/2012/803097 / rank
 
Normal rank
Property / OpenAlex ID
 
Property / OpenAlex ID: W2095294742 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q3331035 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Optimal mix of screening and contact tracing for endemic diseases / rank
 
Normal rank
Property / cites work
 
Property / cites work: A versatile ODE approximation to a network model for the spread of sexually transmitted diseases / rank
 
Normal rank
Property / cites work
 
Property / cites work: Monogamous networks and the spread of sexually transmitted diseases / rank
 
Normal rank
Property / cites work
 
Property / cites work: Contact switching as a control strategy for epidemic outbreaks / rank
 
Normal rank

Latest revision as of 08:28, 5 July 2024

scientific article
Language Label Description Also known as
English
Exploring short-term responses to changes in the control strategy for chlamydia trachomatis
scientific article

    Statements

    Exploring short-term responses to changes in the control strategy for chlamydia trachomatis (English)
    0 references
    0 references
    0 references
    0 references
    19 June 2012
    0 references
    Summary: Chlamydia has a significant impact on public health provision in the developed world. Using pair approximation equations we investigate the efficacy of control programmes for chlamydia on short time scales that are relevant to policy makers. We use output from the model to estimate critical measures, namely, prevalence, incidence, and positivity in those screened and their partners. We combine these measures with a costing tool to estimate the economic impact of different public health strategies. Increasing screening coverage significantly increases the annual programme costs whereas an increase in tracing efficiency initially increases annual costs but over time reduces costs below baseline, with tracing accounting for around 10\% of intervention costs. We found that partner positivity is insensitive to changes in prevalence due to screening, remaining at around 33\%. Whether increases occur in screening or tracing levels, the cost per treated infection increases from the baseline because of reduced prevalence.
    0 references

    Identifiers

    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references